These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Letter: Chemotherapy for erythroleukemia. Bluming A N Engl J Med; 1974 Aug; 291(8):419-20. PubMed ID: 4603175 [No Abstract] [Full Text] [Related]
45. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin]. Schmalzl F; Braunsteiner H Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111 [No Abstract] [Full Text] [Related]
47. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules. Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707 [No Abstract] [Full Text] [Related]
48. Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Bezerra MF; Coelho-Silva JL; Nascimento JC; Benicio MT; Rocha CR; Machado CG; Rego EM; Bezerra MA; Lucena-Araujo AR; Beltrão EI Haematologica; 2017 Feb; 102(2):e43-e46. PubMed ID: 27846614 [No Abstract] [Full Text] [Related]
49. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia. Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615 [No Abstract] [Full Text] [Related]
50. [Steroid therapy of acute leukemia]. Streneva TN Ter Arkh; 1974; 46(8):140-2. PubMed ID: 4529479 [No Abstract] [Full Text] [Related]
51. A 13-years remission in chronic myelocytic leukemia after a single course of busulfan. Weinberger A; Benjamin D; Douer D; Barabash G; Djaldetti M; Pinkhas J Acta Haematol; 1978; 59(6):354-9. PubMed ID: 97894 [TBL] [Abstract][Full Text] [Related]
52. Treatment of acute non-lymphoid leukemias: comparison of two protocols. Hauptmann E; Stacher A; Heinz R; Jaksic B Osterr Z Onkol; 1977 Dec; 4(4):80-2. PubMed ID: 271937 [TBL] [Abstract][Full Text] [Related]
53. Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study. Ohtake S; Miyawaki S; Fujita H; Kiyoi H; Shinagawa K; Usui N; Okumura H; Miyamura K; Nakaseko C; Miyazaki Y; Fujieda A; Nagai T; Yamane T; Taniwaki M; Takahashi M; Yagasaki F; Kimura Y; Asou N; Sakamaki H; Handa H; Honda S; Ohnishi K; Naoe T; Ohno R Blood; 2011 Feb; 117(8):2358-65. PubMed ID: 20693429 [TBL] [Abstract][Full Text] [Related]
55. An unusual initial manifestation of acute leukemia. Desai A; Desai A; Staszewski H; Cunha BA Am J Med; 2012 Dec; 125(12):1173-4. PubMed ID: 23062401 [No Abstract] [Full Text] [Related]
56. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine]. Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634 [No Abstract] [Full Text] [Related]
57. Acute leukaemia in adults. The experience at Royal Prince Alfred hospital, 1965-1970. Wilkinson T; Kronenberg H; Rickard KA Med J Aust; 1972 Apr; 1(16):785-8. PubMed ID: 4503392 [No Abstract] [Full Text] [Related]